| http://www.w3.org/ns/prov#value | - ay provide new therapeutic targets in treatment of this disease,??? says Adam Oaks, a student researcher in the Laboratory of Molecular Neurochemistry at GUMC. ???Understanding how current therapies work with the synucleins is important because the drugs don???t work for all patients, and some are associated with side effects including an increased risk of suicide.??? The study was funded by grant
|
